flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Patients with type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. ⁣ ⁣ Whether treatment with would mitigate these risks is unknown. ⁣ ⁣ FLOW: Kidney outcome results for

Yesvariants in GLP1R, GIPR, FTO, and MC4R genes can substantially reduce how strongly your receptors respond to semaglutide

In addition, cyanocobalamin, a synthetic version of vitamin B12, is often used to treat it

Less attention is paid to whether its safe

Possible Side Effects Most studies report that AOD-9604 has a relatively mild safety profile

363,364,365 Liver organoids generated from expanded hepatic progenitor cells (HPCs) reconstituted hepatic interstitial structures after implantation in allogeneic mice

[1] Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which typically diminish with continued use